CureVac works on mRNA vaccine for coronavirus infection

CureVac is using its vaccine platform and expertise to develop Covid-19 vaccine. Credit: Gerd Altmann from Pixabay.

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

Free Whitepaper

What is the impact of China鈥檚 Zero-COVID lockdowns on economic activity, consumer goods and the foodservice industry?

While wanting to protect the country from being overwhelmed by Omicron, China鈥檚 adherence to a Zero-COVID policy is resulting in a significant economic downturn. COVID outbreaks in Shanghai, Beijing and many other Chinese cities will impact 2022鈥檚 economic growth as consumers and businesses experience rolling lockdowns, leading to a slowdown in domestic and international supply chains. China鈥檚 Zero-COVID policy is having a demonstrable impact on consumer-facing industries. Access GlobalData鈥檚 new whitepaper,聽China in 2022: the impact of China鈥檚 Zero-COVID lockdowns on economic activity, consumer goods and the foodservice industry, to examine the current situation in Shanghai and other cities in China, to better understand the worst-affected industry sectors, foodservice in particular, and to explore potential growth opportunities as China recovers. The white paper covers:

Which multinational companies have been affected?
What is the effect of lockdowns on foodservice?
What is the effect of lockdowns on Chinese ports?
Spotlight on Shanghai: what is the situation there?
How have Chinese consumers reacted?
How might the Chinese government react?
What are the potential growth opportunities?

By GlobalData

By downloading this Whitepaper, you acknowledge that GlobalData may share your information with GlobalData and that your personal data will be used as described in their Privacy Policy

Visit our for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Follow the latest updates of the outbreak聽on our聽timeline.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile 鈥� free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

Tick here to opt out of curated industry news, reports, and event updates from Pharmaceutical Technology.

Visit our for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

German biopharmaceutical company CureVac is working on the development of an mRNA-based vaccine to protect against Covid-19 coronavirus infection.

According to the company, mRNA鈥檚 mechanism of action makes it a potent molecule to offer a quick and efficient solution in case of outbreaks, such as the novel coronavirus pandemic.

CureVac is using its vaccine platform and expertise to develop an effective and safe Covid-19 vaccine.

Recently, the company reported encouraging vaccination data from its Rabies programme, with two doses of one microgram providing complete protection in humans.

These results could offer hope for meeting global supply-demand in a pandemic scenario.

Since 2006, the company has been manufacturing mRNA-based vaccines and therapeutics. It is currently looking to boost its manufacturing capacity to supply up to billions of doses during outbreaks.

CureVac chief technology officer Mariola Fotin-Mleczek said: 鈥淣ature has invented mechanisms to activate our immune system against infectious diseases. With our unique messenger RNA technology, we mimic nature and give our body the information on how to fight against the virus.

鈥淭he combination of mRNA science, disease understanding, formulation and production expertise make CureVac a unique player to fight against any infectious disease, no matter whether they are seasonal or pandemic.鈥�

According to media reports, US President Donald Trump offered to buy exclusive access to a Covid-19 vaccine currently in development by CureVac.

Furthermore, German newspaper Die Welt said, citing German government circles, that the German government is working to fight the takeover.

However, CureVac noted that the company is working with various organisations globally to develop a coronavirus vaccine candidate. It refrained from commenting on 鈥榮peculations鈥� and rejected 鈥榓llegations鈥� of acquisition offers for the company or its technology.

Free Whitepaper

What is the impact of China鈥檚 Zero-COVID lockdowns on economic activity, consumer goods and the foodservice industry?

Which multinational companies have been affected?
What is the effect of lockdowns on foodservice?
What is the effect of lockdowns on Chinese ports?
Spotlight on Shanghai: what is the situation there?
How have Chinese consumers reacted?
How might the Chinese government react?
What are the potential growth opportunities?

By GlobalData

By downloading this Whitepaper, you acknowledge that GlobalData may share your information with GlobalData and that your personal data will be used as described in their Privacy Policy